| Name | Title | Contact Details |
|---|
HemoCORM is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cellectis is developing the first of its kind allogeneic approach for CAR-T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients. As a clinical-stage biopharmaceutical company with over 20 years of expertise in gene editing, Cellectis is developing life-changing product candidates utilizing TALEN®, its proprietary gene editing technology, and PulseAgile, its pioneering electroporation system to harness the power of the immune system in order to target and eradicate cancer cells.
Longs Drug Stores of SC Inc is a Columbia, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Koneksa is a leading patient-centric digital biomarker company for the pharmaceutical and biotechnology industries.